Rhythm Pharmaceuticals Inc.

NASDAQ:RYTM 3:59:52 PM EDT

22.65

+1.52 (+7.19%)

Products

Preventiongenetics Receives FDA Approval For Its Companion Diagnostic Genetic Test As A Class Ii Medical Device

Published: 06/30/2022 15:03 GMT

RYTM

Rhythm Pharmaceuticals Inc. (RYTM) - Preventiongenetics Receives FDA Approval for Its Companion Diagnostic Genetic Test As a Class Ii Medical Device.